SQI Diagnostics Inc V.SQD.H

Healthcare Medical Devices

SQI Diagnostics Inc. is a Canada-based company that is focused on lung health. The Company is engaged in the development and manufacturing of respiratory health and precision medicine tests that run on its fully automated systems. Its clinical solutions include Rapid Acute Lung Injury Diagnostic (RALI-Dx), lung transplant diagnostics, COVID-19 testing and surveillance testing solutions. Its RALI-Dx IL-6 Severity Triage Test and the RALI-fast IL-6 Severity Triage point of care (POC) Test each help clinicians identify which patients with SARS-CoV-2 are predicted to have a severe inflammatory response and should or should not be admitted to the hospital. Its RALI-Dx delivers results from the lab in less than an hour while RALI-fast delivers results at the patient point-of-care in about 15 minutes. The Company’s TORdx LUNG Test measures inflammation at the molecular level to assess the health of the donor lung. The Company is also focused on its organ transplant pipeline of products.

TSXV:SQD.H - Post by User

SQI Diagnostics Inc > Transplant Surgery and Engineering Super-Organs

<< Previous

Bullboard Posts

Next >>

Comment by barryt34on Nov 28, 2020 10:33am

87 Views

Post# 31994309

RE:RE:Transplant Surgery and Engineering Super-Organs

Sqi would have to have testing where they take the organ out of the patient, the location where they are healing the organ and the hospital where the transplant is taking place. That means one of sqi platforms would have to be in all the hospitals, wouldn't this pandemic be the perfect situation to put Sqi platforms in all the hospitals then in the future it could be used for organ transplants.

<< Previous

Bullboard Posts

Next >>

Sony’s Alpha 1 II: A new professional photography standard?